PRODUCT NAME:
Product Name: Digoxin CLIA Kit (Chemiluminescence Immunoassay)
Abbreviation:DIG
INTENDED USE:
Digoxin CLIA Kit (Chemiluminescence Immunoassay) is an in vitro diagnostic test for the quantitative detection of
Digoxin (DIG) in human serum and plasma specimen. This product is intended to be used by laboratory professional
workers only. This kit is used for auxiliary diagnosis. Results must be combined with clinical observations, patient
history, other laboratory parameters, and epidemiological information.
Digoxin is a cardiac glycoside drug, which is mainly used in the clinical treatment of congestive heart failure and
high-volume atrial flutter caused by atrial fibrillation. However, this drug has a narrow therapeutic window and large
individual differences. Even conventional doses may cause poisoning such as vomiting, nausea, palpitations, and chest
tightness. Therefore, it is of great significance to detect the blood concentration of digoxin to ensure the safety of
clinical medication.